Right now, in the right way: U. S. Food and Drug Administration's expanded access program and patient rights

J Clin Transl Sci. 2018 Jun;2(3):115-117. doi: 10.1017/cts.2018.318.
No abstract available

Keywords: Investigational drugs; United States Food and Drug Administration; compassionate use; ethics; legislation; patient rights.

Publication types

  • Editorial